March 7, 2024
As spring approaches, the decision about whether to get an updated COVID-19 dose may be on the minds of Canadians, especially if travel plans are in the works.
In January, the National Advisory Committee on Immunization (NACI) issued guidance for administering an updated dose of COVID-19 vaccines in the spring, specifically for Canadians facing an elevated risk of severe illness from the virus.
“Older adults continue to be at the highest risk of a severe outcome and are less likely to have experienced previous SARS-CoV-2 infection compared to other age groups,” NACI stated.
Since fall 2023, newly revised formulations from Pfizer, Moderna, and Novavax have been accessible to Canadians. The XBB.1.5 COVID-19 vaccines specifically target a more recent lineage of the Omicron variant.
Read more: https://globalnews.ca/news/10338744/covid-booster-spring-canada/